Intercept 213 EU Study

This telemedicine app is intended to be used by patients enrolled in Intercept's 213 EU study. The purpose of this app is to connect patients and clinician's for the purpose of Intercept's study. Patients will use this app to schedule and conduct telemedicine calls.

This app is intended for users who are age 18 and over.